Horan Securities’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$86.1K	Hold	41,590	–	–	0.03%	152
2025 Q1	$91.5K	Buy	+41,590	New	+$91.5K	0.03%	134
2024 Q4	–	Sell	-29,310	Closed	-$58.3K	–	134
2024 Q3	$58.3K	Hold	29,310	–	–	0.02%	139
2024 Q2	$103K	Buy	+29,310	New	+$103K	0.04%	123